Cryosite Ltd

CTE

Company Profile

  • Business description

    Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.

  • Contact

    13a Ferndell Street
    South Granville
    SydneyNSW2142
    AUS

    T: +61 288652000

    https://www.cryosite.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    25

Stocks News & Analysis

stocks

Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Our view on the blockbuster merger.
stocks

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks

New pricing model for embattled ASX tech leader

Investor day shows off potentially disruptive pricing model.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.1019.300.22%
CAC 408,114.747.29-0.09%
DAX 4024,028.14146.110.61%
Dow JONES (US)47,954.99104.050.22%
FTSE 1009,667.0143.86-0.45%
HKSE26,085.08149.180.58%
NASDAQ23,578.1372.990.31%
Nikkei 22550,491.87536.55-1.05%
NZX 50 Index13,483.9931.63-0.23%
S&P 5006,870.4013.280.19%
S&P/ASX 2008,634.6020.500.24%
SSE Composite Index3,902.8127.010.70%

Market Movers